Cargando…

Differential expression of CD8 defines phenotypically distinct cytotoxic T cells in cancer and multiple sclerosis

BACKGROUND: Cytotoxic T lymphocytes take on a leading role in many immune‐related diseases. They function as key effector immune cells fighting cancer cells, but they are also considerably involved in autoimmune diseases. Common to both situations, CD8(+) T cells need to adapt their metabolism and e...

Descripción completa

Detalles Bibliográficos
Autores principales: Burkard, Tobias, Herrero San Juan, Martina, Dreis, Caroline, Kiprina, Anastasiia, Namgaladze, Dmitry, Siebenbrodt, Kai, Luger, Sebastian, Foerch, Christian, Pfeilschifter, Josef M., Weigert, Andreas, Radeke, Heinfried H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742381/
https://www.ncbi.nlm.nih.gov/pubmed/36504430
http://dx.doi.org/10.1002/ctm2.1068
_version_ 1784848503477895168
author Burkard, Tobias
Herrero San Juan, Martina
Dreis, Caroline
Kiprina, Anastasiia
Namgaladze, Dmitry
Siebenbrodt, Kai
Luger, Sebastian
Foerch, Christian
Pfeilschifter, Josef M.
Weigert, Andreas
Radeke, Heinfried H.
author_facet Burkard, Tobias
Herrero San Juan, Martina
Dreis, Caroline
Kiprina, Anastasiia
Namgaladze, Dmitry
Siebenbrodt, Kai
Luger, Sebastian
Foerch, Christian
Pfeilschifter, Josef M.
Weigert, Andreas
Radeke, Heinfried H.
author_sort Burkard, Tobias
collection PubMed
description BACKGROUND: Cytotoxic T lymphocytes take on a leading role in many immune‐related diseases. They function as key effector immune cells fighting cancer cells, but they are also considerably involved in autoimmune diseases. Common to both situations, CD8(+) T cells need to adapt their metabolism and effector function to the harsh and nutrient‐deprived conditions of the disease‐associated microenvironment. METHODS: We used an in vitro starvation as well as rapamycin treatment protocol mimicking nutrient deprivation to generate CD8(Low) versus CD8(High) T cells and performed FACS‐Sorting followed by transcriptomic profiling of the cytotoxic T cell subsets. Prominent markers identified in the CD8(Low) versus the CD8(High) T cells were then used to investigate the presence of these cell subsets in immune‐related human diseases. Employing cancer tissue microarrays and PhenOptics multispectral imaging as well as flow cytometry, we studied these CD8(+) T cell subsets in cancer and relapsing‐remitting multiple sclerosis patients. RESULTS: Starvation induced a decreased expression of CD8, yielding a CD8(Low) T cell subpopulation with an altered transcriptomic signature and reduced effector function. CD8(Low) T cell showed enhanced ST2L and IL6ST (CD130) expression compared to CD8(High) T cells which expressed elevated KLRD1 (CD94) and granzyme B levels within the tumour microenvironment (TME). Spatial analysis revealed the presence of CD8(High) T cells in close proximity to tumour cells, while the CD8(Low) T cells resided at the tumour boundaries. Importantly, the number of tumour‐infiltrating CD8(Low) T lymphocytes correlated with a poor prognosis as well as with enhanced cancer progression in human mammary carcinoma. We also found a reduced frequency of CD8(Low) T lymphocytes in a cohort of relapse (disease active) multiple sclerosis patients compared to healthy subjects during immune cell starvation in vitro. CONCLUSIONS: In summary, our data show that functionally distinct cytotoxic T lymphocytes can be identified based on their expression of CD8. Indicating a more general role in CD8 T cell immunity, these cells may play opposing roles in the TME, and also in the pathophysiology of autoimmune diseases such as multiple sclerosis.
format Online
Article
Text
id pubmed-9742381
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-97423812022-12-13 Differential expression of CD8 defines phenotypically distinct cytotoxic T cells in cancer and multiple sclerosis Burkard, Tobias Herrero San Juan, Martina Dreis, Caroline Kiprina, Anastasiia Namgaladze, Dmitry Siebenbrodt, Kai Luger, Sebastian Foerch, Christian Pfeilschifter, Josef M. Weigert, Andreas Radeke, Heinfried H. Clin Transl Med Research Articles BACKGROUND: Cytotoxic T lymphocytes take on a leading role in many immune‐related diseases. They function as key effector immune cells fighting cancer cells, but they are also considerably involved in autoimmune diseases. Common to both situations, CD8(+) T cells need to adapt their metabolism and effector function to the harsh and nutrient‐deprived conditions of the disease‐associated microenvironment. METHODS: We used an in vitro starvation as well as rapamycin treatment protocol mimicking nutrient deprivation to generate CD8(Low) versus CD8(High) T cells and performed FACS‐Sorting followed by transcriptomic profiling of the cytotoxic T cell subsets. Prominent markers identified in the CD8(Low) versus the CD8(High) T cells were then used to investigate the presence of these cell subsets in immune‐related human diseases. Employing cancer tissue microarrays and PhenOptics multispectral imaging as well as flow cytometry, we studied these CD8(+) T cell subsets in cancer and relapsing‐remitting multiple sclerosis patients. RESULTS: Starvation induced a decreased expression of CD8, yielding a CD8(Low) T cell subpopulation with an altered transcriptomic signature and reduced effector function. CD8(Low) T cell showed enhanced ST2L and IL6ST (CD130) expression compared to CD8(High) T cells which expressed elevated KLRD1 (CD94) and granzyme B levels within the tumour microenvironment (TME). Spatial analysis revealed the presence of CD8(High) T cells in close proximity to tumour cells, while the CD8(Low) T cells resided at the tumour boundaries. Importantly, the number of tumour‐infiltrating CD8(Low) T lymphocytes correlated with a poor prognosis as well as with enhanced cancer progression in human mammary carcinoma. We also found a reduced frequency of CD8(Low) T lymphocytes in a cohort of relapse (disease active) multiple sclerosis patients compared to healthy subjects during immune cell starvation in vitro. CONCLUSIONS: In summary, our data show that functionally distinct cytotoxic T lymphocytes can be identified based on their expression of CD8. Indicating a more general role in CD8 T cell immunity, these cells may play opposing roles in the TME, and also in the pathophysiology of autoimmune diseases such as multiple sclerosis. John Wiley and Sons Inc. 2022-12-11 /pmc/articles/PMC9742381/ /pubmed/36504430 http://dx.doi.org/10.1002/ctm2.1068 Text en © 2022 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Burkard, Tobias
Herrero San Juan, Martina
Dreis, Caroline
Kiprina, Anastasiia
Namgaladze, Dmitry
Siebenbrodt, Kai
Luger, Sebastian
Foerch, Christian
Pfeilschifter, Josef M.
Weigert, Andreas
Radeke, Heinfried H.
Differential expression of CD8 defines phenotypically distinct cytotoxic T cells in cancer and multiple sclerosis
title Differential expression of CD8 defines phenotypically distinct cytotoxic T cells in cancer and multiple sclerosis
title_full Differential expression of CD8 defines phenotypically distinct cytotoxic T cells in cancer and multiple sclerosis
title_fullStr Differential expression of CD8 defines phenotypically distinct cytotoxic T cells in cancer and multiple sclerosis
title_full_unstemmed Differential expression of CD8 defines phenotypically distinct cytotoxic T cells in cancer and multiple sclerosis
title_short Differential expression of CD8 defines phenotypically distinct cytotoxic T cells in cancer and multiple sclerosis
title_sort differential expression of cd8 defines phenotypically distinct cytotoxic t cells in cancer and multiple sclerosis
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742381/
https://www.ncbi.nlm.nih.gov/pubmed/36504430
http://dx.doi.org/10.1002/ctm2.1068
work_keys_str_mv AT burkardtobias differentialexpressionofcd8definesphenotypicallydistinctcytotoxictcellsincancerandmultiplesclerosis
AT herrerosanjuanmartina differentialexpressionofcd8definesphenotypicallydistinctcytotoxictcellsincancerandmultiplesclerosis
AT dreiscaroline differentialexpressionofcd8definesphenotypicallydistinctcytotoxictcellsincancerandmultiplesclerosis
AT kiprinaanastasiia differentialexpressionofcd8definesphenotypicallydistinctcytotoxictcellsincancerandmultiplesclerosis
AT namgaladzedmitry differentialexpressionofcd8definesphenotypicallydistinctcytotoxictcellsincancerandmultiplesclerosis
AT siebenbrodtkai differentialexpressionofcd8definesphenotypicallydistinctcytotoxictcellsincancerandmultiplesclerosis
AT lugersebastian differentialexpressionofcd8definesphenotypicallydistinctcytotoxictcellsincancerandmultiplesclerosis
AT foerchchristian differentialexpressionofcd8definesphenotypicallydistinctcytotoxictcellsincancerandmultiplesclerosis
AT pfeilschifterjosefm differentialexpressionofcd8definesphenotypicallydistinctcytotoxictcellsincancerandmultiplesclerosis
AT weigertandreas differentialexpressionofcd8definesphenotypicallydistinctcytotoxictcellsincancerandmultiplesclerosis
AT radekeheinfriedh differentialexpressionofcd8definesphenotypicallydistinctcytotoxictcellsincancerandmultiplesclerosis